Sandoz Leadership
Under the leadership of Richard Saynor, the Sandoz Executive Committee (SEC) is responsible for overseeing the business operations of Sandoz. The SEC is made up of a diverse team of leaders with extensive experience in the generic pharmaceutical and biopharmaceutical industry. Each member of the SEC represents a specific region, business unit or global function. They share a commitment to helping people around the world access high quality medicine.
Richard Saynor
CEO, Sandoz
Francisco Ballester
Head of International Region
Giovanni Barbella
External Supply Operations, Novartis Technical Operations
Martin Bischof
Ad interim, Head of Europe
Pierre Bourdage
Global Head of Biopharmaceuticals
Philippe Deecke
Chief Financial Officer
Subodh Deshmukh
Global Head of Product Development
Michael Gyr
Ad interim, Head of Ethics, Risk and Compliance
Andre Heeg
Head of Digital
Steffen Kurzawa
Global Head of Communications
Carol Lynch
President of Sandoz US and Head of North America
Inge Maes
Global Head People & Organization
Christian Pawlu
Head of Strategy, Portfolio and BD&L
Ingrid Sollerer
General Counsel & Global Head of Legal